Exploration of copper-cysteamine nanoparticles as a new type of agents for antimicrobial photodynamic inactivation

Liyi Huang*, Lun Ma, Weijun Xuan, Xiumei Zhen, Han Zheng, Wei Chen, Michael R. Hamblin

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

25 Citations (Scopus)

Abstract

Copper-cysteamine (Cu-Cy) nanoparticles (NPs) are a new type of sensitizers that can be activated by UV light, X-rays, microwaves and ultrasound to produce reactive oxygen species for cancer treatment. Here, for the first time, we explored Cu-Cy NPs for bacteria inactivation by treating gram-positive bacteria (methicillin-resistant Staphylococcus aureus and Enterococcus faecalis) and gram-negative bacteria (Escherichia coli and Acinetobacter baumannii), respectively. The results show that Cu-Cy NPs are very effective in killing gram-positive bacteria but are quite limited in killing gram-negative bacteria yet. The major killing mechanism is cell damage by singlet oxygen and Cu-Cy NPs are potential agents for bacteria inactivation.

Original languageEnglish
Pages (from-to)2142-2148
Number of pages7
JournalJournal of Biomedical Nanotechnology
Volume15
Issue number10
DOIs
Publication statusPublished - 2019
Externally publishedYes

Keywords

  • Antimicrobial photodynamic inactivation
  • Copper-cysteamine nanoparticles
  • Gram-negative bacteria
  • Gram-positive bacteria
  • Reactive oxygen species

Fingerprint

Dive into the research topics of 'Exploration of copper-cysteamine nanoparticles as a new type of agents for antimicrobial photodynamic inactivation'. Together they form a unique fingerprint.

Cite this